Novel Inhibitor of Adenovirus Gene Transfer

Novel inhibitor of the type III secretion system (T3SS), acting as a anti-microbial agent against Xanthomonas oryzae pv. oryzae (Xoo)

Type-A trichothecene mycotoxin

Selective class D inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

Selective class B inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

Novel potent PPARγ antagonist with much improved drug-like properties and promising pharmacokinetic profile

Potent and selective CCKA receptor antagonist

Novel COX-2 inhibitor

Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD

K+ channel blocker

Novel microtubule-stablizer

Novel Mycobacterium tuberculosis growth inhibitor

Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence

Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml

Novel inhibitor of the Syk kinase (spleen tyrosine kinase)

Novel universal opioid receptor agonist

Novel highly potent and selective CDK7 inhibitor, demonstrating broad anti-tumor activity in vivo

Novel selective OXE receptor antagonist

Potent differentiating agent

Natural potent alpha-mannosidase inhibitor, exhibiting antimetastatic, antiproliferative, and immunomodulatory activities

Novel clickable tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD)

D2 dopamine receptor partial agonist in adenylyl cyclase inhibition assay and antagonist in the GIRK and phospho ERK1/2 assays

Selective D2 dopamine receptor antagonist

Antagonist of the mammalian bile acid sensor farnesoid-X-receptor (FXR)

Potent Inhibitor of Plasmodium FK506 Binding Protein 35 (FKBD35), also act as a HIV inhibitor

5-HT2 antagonist

Novel fibroblast growth factor receptor modulator for treating neurodegenerative diseases

D2 selective dopamine agonist, showing anxiolytic and anti-parkinsonian activities

Novel, potent, selective, and competitive antagonist of LTD4 and LTE4

Peripheral vasodilator